The enantioselective 1,3-dipolar cycloaddition of nitrones and arylpropionaldehydes to generate highly functionalized scaffolds for application in drug discovery was herein investigated. The use of a second-generation MacMillan catalyst as hydrochloride salt consistently accelerated the reaction speed, allowing a decrease in the reaction time up to >100 times, still affording 4-isoxazolines with good to excellent enantiomeric ratios at room temperature. As a proof of concept, further functionalization of the isoxazoline core through Pd-catalyzed cross-coupling was performed, generating differently functionalized chemical architectures in high yield.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9352246PMC
http://dx.doi.org/10.1021/acsomega.2c03477DOI Listing

Publication Analysis

Top Keywords

fast macmillan's
4
macmillan's imidazolidinone-catalyzed
4
imidazolidinone-catalyzed enantioselective
4
enantioselective synthesis
4
synthesis polyfunctionalized
4
polyfunctionalized 4-isoxazoline
4
4-isoxazoline scaffolds
4
scaffolds enantioselective
4
enantioselective 13-dipolar
4
13-dipolar cycloaddition
4

Similar Publications

Carboxylate-Capped Analogues of Ru265 Are MCU Inhibitor Prodrugs.

Inorg Chem

October 2022

Department of Chemistry and Chemical Biology, Cornell University, Ithaca, New York 14853, United States.

The mitochondrial calcium uniporter (MCU) is a transmembrane protein that resides on the inner membrane of the mitochondria and mediates calcium uptake into this organelle. Given the critical role of mitochondrial calcium trafficking in cellular function, inhibitors of this channel have arisen as tools for studying the biological relevance of this process and as potential therapeutic agents. In this study, four new analogues of the previously reported Ru-based MCU inhibitor [ClRu(NH)(μ-N)Ru(NH)Cl]Cl (Ru265) are reported.

View Article and Find Full Text PDF

The enantioselective 1,3-dipolar cycloaddition of nitrones and arylpropionaldehydes to generate highly functionalized scaffolds for application in drug discovery was herein investigated. The use of a second-generation MacMillan catalyst as hydrochloride salt consistently accelerated the reaction speed, allowing a decrease in the reaction time up to >100 times, still affording 4-isoxazolines with good to excellent enantiomeric ratios at room temperature. As a proof of concept, further functionalization of the isoxazoline core through Pd-catalyzed cross-coupling was performed, generating differently functionalized chemical architectures in high yield.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!